NO20083213L - Farmasoytisk sammensetning inneholdende montelukast - Google Patents

Farmasoytisk sammensetning inneholdende montelukast

Info

Publication number
NO20083213L
NO20083213L NO20083213A NO20083213A NO20083213L NO 20083213 L NO20083213 L NO 20083213L NO 20083213 A NO20083213 A NO 20083213A NO 20083213 A NO20083213 A NO 20083213A NO 20083213 L NO20083213 L NO 20083213L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
composition containing
montelukast
containing montelukast
active ingredient
Prior art date
Application number
NO20083213A
Other languages
English (en)
Norwegian (no)
Inventor
Vesna Kroselj
Renata Osolnik
Turk Urska
Bevec Franci
Original Assignee
Krka Tovarna Zdravil Dd Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2006/070045 external-priority patent/WO2007077135A1/en
Application filed by Krka Tovarna Zdravil Dd Novo Mesto filed Critical Krka Tovarna Zdravil Dd Novo Mesto
Publication of NO20083213L publication Critical patent/NO20083213L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20083213A 2005-12-30 2008-07-18 Farmasoytisk sammensetning inneholdende montelukast NO20083213L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05113112A EP1803457A1 (de) 2005-12-30 2005-12-30 Pharmazeutische Zubereitung, welche Montelukast enthält
PCT/EP2006/070045 WO2007077135A1 (en) 2005-12-30 2006-12-20 Pharmaceutical composition containing montelukast

Publications (1)

Publication Number Publication Date
NO20083213L true NO20083213L (no) 2008-09-26

Family

ID=35658888

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083213A NO20083213L (no) 2005-12-30 2008-07-18 Farmasoytisk sammensetning inneholdende montelukast

Country Status (3)

Country Link
EP (1) EP1803457A1 (de)
NO (1) NO20083213L (de)
UA (1) UA97355C2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006337648A1 (en) * 2006-02-09 2007-08-16 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical formulations of montelukast sodium
CN101732268B (zh) * 2010-01-09 2012-12-05 鲁南制药集团股份有限公司 一种孟鲁司特钠片剂及其制备方法
WO2011105539A1 (ja) * 2010-02-26 2011-09-01 東レ株式会社 被覆固形製剤
CN108888602B (zh) * 2018-08-16 2021-04-06 海南锦瑞制药有限公司 一种孟鲁司特钠制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2347856C (en) * 1998-11-13 2009-02-17 Jago Research Ag Dry powder for inhalation
EP1487407A4 (de) * 2002-03-12 2010-08-25 Microdose Therapeutx Inc Situsspezifische abgabe von gleichzeitig verabreichten arzneimitteln durch inhalation
GB0312148D0 (en) * 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
US7553853B2 (en) * 2003-10-10 2009-06-30 Synthon Bv Solid-state montelukast
GB0326632D0 (en) * 2003-11-14 2003-12-17 Jagotec Ag Dry powder formulations
KR20060117356A (ko) * 2004-01-30 2006-11-16 테바 파마슈티컬 인더스트리즈 리미티드 몬테루카스트 유리산 다형체

Also Published As

Publication number Publication date
EP1803457A1 (de) 2007-07-04
UA97355C2 (ru) 2012-02-10

Similar Documents

Publication Publication Date Title
NO20090328L (no) Nye forbindelser 385
WO2010018113A3 (en) Bi-aryl aminotetralines
NO20045072L (no) Tablett med hoyt medikamentinnhold
UA84048C2 (ru) Производные сульфонамида для лечения заболеваний, способ их получения (варианты), фармацевтическая композиция на их основе
NO20082673L (no) Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
WO2008094992A3 (en) 2-aminopyridine derivatives useful as kinase inhibitors
JP2009502835A (ja) レベチラセタムを含む薬剤組成物及びその調製方法
NO20082498L (no) Diarylurea for behandling av pulmonar hypertensjon
WO2010018109A3 (en) Substituted aminotetralines
WO2008144730A3 (en) Stable pharmaceutical formulation for a dpp-iv inhibitor
NO20070445L (no) Pyrimidinderivater.
NO20060208L (no) Farmasoytisk preparat
MY151295A (en) Pyrimidyl indoline compound
TN2012000246A1 (en) Pharmaceutical compositions comprising sigma receptor ligands
WO2008133330A1 (ja) ４，５－エポキシモルヒナン誘導体を含有する安定な固形製剤
UA96633C2 (uk) Лікарський засіб, що містить похідне карбостирилу і донепезил, для лікування хвороби альцгеймера
WO2008131469A3 (de) Verfahren zur herstellung von hoch reinem 2,4 '-dimethyl-3-piperidino-propiophenon (tolperison), dieses enthaltende pharmazeutische zusammensetzungen, sowie tolperison enthaltende wirkstoffformulierungen
WO2004078105A3 (fr) Composition de fondaparinux sodique de haute purete
WO2005079759A3 (en) Pharmaceutical composition for oral application and method for preparing thereof
NO20083213L (no) Farmasoytisk sammensetning inneholdende montelukast
NO20085052L (no) 4-((fluorofenoksyl)fenylmetyl)piperidin metansulfonat: anvendelser, synteseprosess og farmasoytiske sammensetninger
NZ591204A (en) Pharmaceutical compositions and methods for stabilizing the same
EA200801614A1 (ru) Фармацевтическая композиция, содержащая монтелукаст
NO20070952L (no) Formuleringer av suberoylanilidhydroksaminsyre og fremgangsmate for fremstilling av slike
WO2011056785A3 (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application